Intrinsic alterations in the skin of patients with vitiligo include a thicker epidermis with a reduced number of basal melanocytes and the presence of degenerated keratinocytes with swollen ...
Vitiligo is a multifactorial skin disorder characterised by the loss of epidermal melanocytes, leading to depigmented patches with significant psychosocial impact. Genetic susceptibility loci, ...
What's new concerning our understanding of vitiligo? Find out in this easy-to-navigate collection of recent MEDLINE abstracts compiled by the editors at Medscape Dermatology. Objective: To assess the ...
Trained immunity, which refers to a sustained enhancement of innate memory function, could potentially serve as an amplifier and persistent catalyst in the development of vitiligo. Vitiligo is an ...
Vitiligo is an autoimmune disease with complex epidemiology, involving genetic, autoimmune, and environmental factors, and is associated with other autoimmune comorbidities. It presents in multiple ...
Vitiligo is a long-lasting condition that causes a loss of color in patches on the skin. It happens when the body's immune system mistakenly attacks and destroys the skin cells that make color or ...
Vitiligo causes light or white patches to form on the skin. It can affect anyone but is often more noticeable in Black people and those with darker skin tones. This can lead to other issues, such as ...
Vitiligo is a condition that causes areas of skin to lose color, which is known as depigmentation. There are no ways to prevent vitiligo from developing, but treatment can help prevent it affecting ...
A small case-control study linked higher Dietary Inflammatory Index scores with progressive vitiligo, suggesting that ...
Adding twice-weekly narrowband UVB phototherapy to oral ritlecitinib may enhance response to treatment of nonsegmental vitiligo. Dual treatment was well-tolerated with no new safety signals in this ...
Zacks Small Cap Research on MSN
EDSA: Preparing for mid-2026 start to phase 2 vitiligo trial
By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Vitiligo Trial to Initiate in Mid-2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results